DMII
Drugs Made In America Acquisition II Corp. Ordinary SharesNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$640.82M
P/E Ratio
77.38
EPS
$0.13
Beta
—
52W High
$10.06
52W Low
$9.86
50-Day MA
$10.00
200-Day MA
$9.97
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) dedicated to merging with innovative entities in the pharmaceuticals and biotechnology industries, with a particular emphasis on bolstering domestic drug manufacturing. With a robust management team's extensive expertise, DMII seeks to execute strategic transactions that align with evolving market demands and prioritize sustainable practices. The company is committed to enhancing supply chain resilience and promoting U.S. healthcare self-sufficiency, ultimately aiming to generate long-term value for shareholders while contributing to the growth and advancement of the American pharmaceutical sector.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -812,113 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.32% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | 1.30 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $63.70M |
| Float | $50.26M |
| % Insiders | 15.21% |
| % Institutions | 70.55% |
Historical Volatility
HV 10-Day
1.12%
HV 20-Day
1.04%
HV 30-Day
1.08%
HV 60-Day
1.56%
HV Rank
—
Volatility is currently expanding
More FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026